| |
Latest 10 SEC filings (by transaction date) for ADVM within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 14/24 | Feb 12/24 | Seyedkazemi Setareh | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 400,000 | |
Feb 14/24 | Feb 12/24 | Fischer Laurent | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 1,104,200 | |
Feb 14/24 | Feb 12/24 | Rubinstein Linda M | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 350,000 | |
Feb 14/24 | Feb 12/24 | Soparkar Peter | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 450,000 | |
Feb 9/24 | Feb 7/24 | Scopa James Paul | Direct Ownership | Common Stock | P - Open market or private purchase | 100,000 | $1.35 |
Feb 9/24 | Feb 7/24 | Lupher, Jr. Mark L. | Direct Ownership | Common Stock | P - Open market or private purchase | 130,000 | $1.35 |
Nov 6/23 | Nov 6/23 | Nicholson, C. David | Direct Ownership | No securities owned. | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Nov 6/23 | Nov 3/23 | Nicholson, C. David | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 80,000 | |
Mar 12/24 | Oct 3/23 | Seyedkazemi Setareh | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 85,000 | |
Mar 12/24 | Oct 3/23 | Soparkar Peter | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 130,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ADVM within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 12/24 | Oct 3/23 | Seyedkazemi Setareh | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 85,000 | |
Mar 12/24 | Oct 3/23 | Soparkar Peter | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 130,000 | |
Mar 12/24 | Oct 3/23 | Fischer Laurent | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 315,000 | |
Feb 14/24 | Feb 12/24 | Seyedkazemi Setareh | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 400,000 | |
Feb 14/24 | Feb 12/24 | Fischer Laurent | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 1,104,200 | |
Feb 14/24 | Feb 12/24 | Rubinstein Linda M | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 350,000 | |
Feb 14/24 | Feb 12/24 | Soparkar Peter | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 450,000 | |
Feb 9/24 | Feb 7/24 | Scopa James Paul | Direct Ownership | Common Stock | P - Open market or private purchase | 100,000 | $1.35 |
Feb 9/24 | Feb 7/24 | Lupher, Jr. Mark L. | Direct Ownership | Common Stock | P - Open market or private purchase | 130,000 | $1.35 |
Nov 6/23 | Nov 3/23 | Nicholson, C. David | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 80,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |